The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis
Open accessAbstract
Signs or symptoms of impaired autonomic regulation of the circulation often attend Parkinson disease (PD). This review covers biomarkers and mechanisms of autonomic cardiovascular abnormalities in PD and related alpha-synucleinopathies. The clearest clinical laboratory correlate of dysautonomia in PD is loss of myocardial noradrenergic innervation, detected by cardiac sympathetic neuroimaging. About 30–40% of PD patients have orthostatic hypotension (OH), defined as a persistent, consistent fall in systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of change in position from supine to standing. Neuroimaging evidence of cardiac sympathetic denervation is universal in PD with OH (PD+OH). In PD without OH about half the patients have diffuse left ventricular myocardial sympathetic denervation, a substantial minority have partial denervation confined to the inferolateral or apical walls, and a small number have normal innervation. Among patients with partial denervation the neuronal loss invariably progresses over time, and in those with normal innervation at least some loss eventually becomes evident. Thus, cardiac sympathetic denervation in PD occurs independently of the movement disorder. PD+OH also entails extra-cardiac noradrenergic denervation, but this is not as severe as in pure autonomic failure. PD+OH patients have failure of both the parasympathetic and sympathetic components of the arterial baroreflex. OH in PD therefore seems to reflect a “triple whammy” of cardiac and extra-cardiac noradrenergic denervation and baroreflex failure. In contrast, most patients with multiple system atrophy, which can resemble PD+OH clinically, do not have evidence for cardiac or extra-cardiac noradrenergic denervation. Catecholamines in the neuronal cytoplasm are potentially toxic, via spontaneous and enzyme-catalyzed oxidation. Normally cytoplasmic catecholamines are efficiently taken up into vesicles via the vesicular monoamine transporter. The recent finding of decreased vesicular uptake in Lewy body diseases therefore suggests a pathogenetic mechanism for loss of catecholaminergic neurons in the periphery and brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., & Lennon, V. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431204 · Cited by 674
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534
Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration
Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Di Monte, D. A., Emson, P. C., & Miller, G. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 388
Prevalence of orthostatic hypotension in Parkinson’s disease: A systematic review and meta-analysis
Velseboer, D. C., de Haan, R. J., Wieling, W., Goldstein, D. S., & de Bie, R. M. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.04.016 · Cited by 355
Self-citationRahman, F., Pechnik, S., Gross, D., Sewell, L., & Goldstein, D. S. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-010-0098-y · Cited by 336
Self-citationDysautonomia in Parkinson's disease: neurocardiological abnormalities
Goldstein, D. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00555-6 · Cited by 327
Self-citationSympathetic Cardioneuropathy in Dysautonomias
Goldstein, D. S., Holmes, C., Cannon, R. O., Eisenhofer, G., & Kopin, I. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361004 · Cited by 324
Self-citationPharmacologic distinction of different orthostatic hypotension syndromes
Polinsky, R. J., Kopin, I. J., Ebert, M. H., & Weise, V. (1981) · Neurology · doi:10.1212/wnl.31.1.1 · Cited by 296
Marchitti, S. A., Deitrich, R. A., & Vasiliou, V. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.1 · Cited by 280
Taylor, T. N., Caudle, W. M., Shepherd, K. R., Noorian, A., Jackson, C. R., Iuvone, P. M., Weinshenker, D., Greene, J. G., & Miller, G. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1495-09.2009 · Cited by 277
Orthostatic hypotension from sympathetic denervation in Parkinson’s disease
Goldstein, D. S., Holmes, C. S., Dendi, R., Bruce, S. R., & Li, S.-T. (2002) · Neurology · doi:10.1212/wnl.58.8.1247 · Cited by 257
Self-citationPlasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
Goldstein, D. S., Eisenhofer, G., Stull, R., Folio, C. J., Keiser, H. R., & Kopin, I. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113298 · Cited by 245
Self-citationAggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
Burke, W. J., Kumar, V. B., Pandey, N., Panneton, W. M., Gan, Q., Franko, M. W., O’Dell, M., Li, S. W., Pan, Y., Chung, H. D., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0303-9 · Cited by 243
Neurogenic Orthostatic Hypotension: A Pathophysiological Approach
Goldstein, D. S., & Sharabi, Y. (2009) · Circulation · doi:10.1161/circulationaha.108.805887 · Cited by 202
Self-citationOrthostatic hypotension as an early finding in Parkinson’s disease
Goldstein, D. S. (2006) · Clinical Autonomic Research · doi:10.1007/s10286-006-0317-8 · Cited by 201
Self-citationValue of 123 I-MIBG radioactivity in the differential diagnosis of DLB from AD
Yoshita, M., Taki, J., Yokoyama, K., Noguchi-Shinohara, M., Matsumoto, Y., Nakajima, K., & Yamada, M. (2006) · Neurology · doi:10.1212/01.wnl.0000219640.59984.a7 · Cited by 185
Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease
Amino, T., Orimo, S., Itoh, Y., Takahashi, A., Uchihara, T., & Mizusawa, H. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00097.x · Cited by 183
(1964) · The Lancet · doi:10.1016/s0140-6736(64)92683-2 · Cited by 178
Norepinephrine Precursor Therapy in Neurogenic Orthostatic Hypotension
Kaufmann, H., Saadia, D., Voustianiouk, A., Goldstein, D. S., Holmes, C., Yahr, M. D., Nardin, R., & Freeman, R. (2003) · Circulation · doi:10.1161/01.cir.0000083721.49847.d7 · Cited by 177
Self-citationSympathetically Mediated Hypertension in Autonomic Failure
Shannon, J. R., Jordan, J., Diedrich, A., Pohar, B., Black, B. K., Robertson, D., & Biaggioni, I. (2000) · Circulation · doi:10.1161/01.cir.101.23.2710 · Cited by 173
Goldstein, D. S., Holmes, C., Bentho, O., Sato, T., Moak, J., Sharabi, Y., Imrich, R., Conant, S., & Eldadah, B. A. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.010 · Cited by 158
Self-citationOrimo, S. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.776 · Cited by 150
Goldstein, D. S., Eldadah, B. A., Holmes, C. S., Pechnik, S., Moak, J. P., Saleem, A., & Sharabi, Y. (2005) · Hypertension · doi:10.1161/01.hyp.0000188052.69549.e4 · Cited by 140
Self-citationCatechols in post-mortem brain of patients with Parkinson disease
Goldstein, D. S., Sullivan, P., Holmes, C. S., Kopin, I. J., Basile, M. J., & Mash, D. C. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03246.x · Cited by 137
Self-citationPanneton, W. M., Kumar, V. B., Gan, Q., Burke, W. J., & Galvin, J. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015251 · Cited by 137
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension
Goldstein, D. S., Holmes, C. S., Sharabi, Y., Brentzel, S., & Eisenhofer, G. (2003) · Neurology · doi:10.1212/01.wnl.0000058766.46428.f3 · Cited by 136
Self-citationKashihara, K., Imamura, T., & Shinya, T. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.12.010 · Cited by 125
Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy
Orimo, S., Kanazawa, T., Nakamura, A., Uchihara, T., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0160-y · Cited by 122
Adrenergic and Vagal Baroreflex Sensitivity in Autonomic Failure
Schrezenmaier, C., Singer, W., Swift, N. M., Sletten, D. M., Tanabe, J., & Low, P. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.381 · Cited by 115
Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat
Mitchell, I., Lawson, S. J., Moser, B., Laidlaw, S. M., Cooper, A. J., Walkinshaw, G., & Waters, C. M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90002-7 · Cited by 114
Jinsmaa, Y., Florang, V. R., Rees, J. N., Anderson, D. G., Strack, S., & Doorn, J. A. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800405v · Cited by 106
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
Lamensdorf, I., Eisenhofer, G., Harvey-White, J. D., Nechushtan, A., Kirk, K. L., & Kopin, I. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02309-x · Cited by 105
Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension
Sénard, J., Valet, P., Durrieu, G., Berlan, M., Tran, M. A., Montastruc, J., Rascol, A., & Montastruc, P. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01909.x · Cited by 103
Cardiac sympathetic denervation preceding motor signs in Parkinson disease
Goldstein, D. S., Sharabi, Y., Karp, B. I., Bentho, O., Saleem, A., Pacák, K., & Eisenhofer, G. (2007) · Clinical Autonomic Research · doi:10.1007/s10286-007-0396-1 · Cited by 96
Self-citationProgressive loss of cardiac sympathetic innervation in Parkinson's disease
Li, S., Dendi, R., Holmes, C. S., & Goldstein, D. S. (2002) · Annals of Neurology · doi:10.1002/ana.10236 · Cited by 96
Self-citationLamensdorf, I., Eisenhofer, G., Harvey-White, J. D., Hayakawa, Y., Kirk, K., & Kopin, I. J. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000515)60:4<552::aid-jnr14>3.0.co;2-u · Cited by 90
Autonomic dysfunction in PD: A window to early detection?
Goldstein, D. S., Sewell, L., & Sharabi, Y. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.011 · Cited by 78
Self-citationIntra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases
Goldstein, D. S., Holmes, C. S., Kopin, I. J., & Sharabi, Y. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45803 · Cited by 77
Self-citationMoak, J. P., Goldstein, D. S., Eldadah, B. A., Saleem, A., Holmes, C. S., Pechnik, S., & Sharabi, Y. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s2.11 · Cited by 67
Self-citationAssociation of anosmia with autonomic failure in Parkinson disease
Goldstein, D. S., Sewell, L., & Holmes, C. S. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ca014c · Cited by 65
Self-citationNoninvasive detection of sympathetic neurocirculatory failure
Goldstein, D. S., & Tack, C. J. (2000) · Clinical Autonomic Research · doi:10.1007/bf02281111 · Cited by 63
Self-citationSénard, J., Rascol, O., Durrieu, G., Tran, M. A., Berlan, M., Rascol, A., & Montastruc, J. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199302000-00008 · Cited by 60
Goldstein, D. S., Holmes, C. S., Dendi, R., Li, S., Brentzel, S., & Vernino, S. A. (2002) · Clinical Autonomic Research · doi:10.1007/s10286-002-0020-3 · Cited by 49
Self-citationGoldstein, D. S., Holmes, C. S., Sewell, L., Park, M. Y., & Sharabi, Y. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0136-4 · Cited by 49
Self-citationFunctional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension
Imrich, R., Eldadah, B. A., Bentho, O., Pechnik, S., Sharabi, Y., Holmes, C. S., Grossman, E., & Goldstein, D. S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.002 · Cited by 47
Self-citationAutoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab
Imrich, R., Vernino, S. A., Eldadah, B. A., Holmes, C. S., & Goldstein, D. S. (2009) · Clinical Autonomic Research · doi:10.1007/s10286-009-0012-7 · Cited by 44
Self-citationTREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION WITH A MONOAMINE OXIDASE INHIBITOR AND TYRAMINE
NANDA, R., Johnson, R. H., & Keogh, H. J. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91681-0 · Cited by 42
Neurotransmitter specificity of sympathetic denervation in Parkinson’s disease
Sharabi, Y., Li, S.-T., Dendi, R., Holmes, C. S., & Goldstein, D. S. (2003) · Neurology · doi:10.1212/01.wnl.0000052690.91036.ff · Cited by 39
Self-citationNeuropharmacologic Distinction of Neurogenic Orthostatic Hypotension Syndromes
Sharabi, Y., Eldadah, B. A., Li, S., Dendi, R., Pechnik, S., Holmes, C. S., & Goldstein, D. S. (2006) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000220822.80640.0d · Cited by 34
Self-citationCardiac sympathetic neuroimaging: summary of the First International Symposium
Goldstein, D. S., & Orimo, S. (2009) · Clinical Autonomic Research · doi:10.1007/s10286-009-0002-9 · Cited by 32
Self-citation
Cited by
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Cacabelos, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030551 · Cited by 555
Freeman, R., Abuzinadah, A. R., Gibbons, C., Jones, P., Miglis, M. G., & Sinn, D. I. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.079 · Cited by 280
Finucane, C., O’Connell, M. D. L., Fan, C. W., Savva, G. M., Soraghan, C. J., Nolan, H., Cronin, H., & Kenny, R. A. (2014) · Circulation · doi:10.1161/circulationaha.114.009831 · Cited by 219
Ungar, A., Mussi, C., Ceccofiglio, A., Bellelli, G., Nicosia, F., Bo, M., Riccio, D., Martone, A. M., Guadagno, L., Noro, G., et al. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14225 · Cited by 80
Fanciulli, A., Strano, S., Ndayisaba, J. P., Goebel, G., Gioffrè, L., Rizzo, M., Colosimo, C., Caltagirone, C., Poewe, W., Wenning, G. K., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7339-2 · Cited by 67
Metadata
- Authors
- Jain, S., & Goldstein, D. S.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 46
- Issue
- 3
- Pages
- 572-580
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2046969478
- Cited by
- 297
- References
- 52
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.